fda approved glutathione iv Compounded Injection FDA highlights concerns with using

Recently, our group showed that orally dosed GGC (2 and 4 g) is bioavailable and can increase intracellular GSH levels above homeostasis in lymphocytes of healthy, non-fasting human subjects with no adverse effects (Zarka and Bridge, In conclusion, this study has shown that GGC can decrease apoptosis, oxidative stress and inflammation in human astrocytes and protect astrocytes from oligomeric A 40 -mediated cytotoxicity cellular GSH depletion

The largest human trial had only 16 test subjects, which means that if BPC-157 had, say, a 1% risk of a truly catastrophic side effect, a test like that would have a very small chance of catching it

CAS Number: 89030-95-5

Maroon is also Chairman of the Medical advisory board of General Nutrition Centers (GNC)

Endocrine (2010) 38(2):16773